Plasminogen activator
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{STRUCTURE_1a5h| PDB=1a5h | SIZE=400| SCENE= |right| CAPTION=Human tissue plasminogen activator light chain catalytic domain (grey and green), heavy chain catalytic domain fragment (yellow and pink) complex with benzamidine, [[1a5h]] }} | {{STRUCTURE_1a5h| PDB=1a5h | SIZE=400| SCENE= |right| CAPTION=Human tissue plasminogen activator light chain catalytic domain (grey and green), heavy chain catalytic domain fragment (yellow and pink) complex with benzamidine, [[1a5h]] }} | ||
| - | '''Plasminogen activator''' (PLA) is a serine protease which converts plasminogen to plasmin | + | '''Plasminogen activator''' (PLA) is a serine protease which converts plasminogen to plasmin. TPA structure contains heavy and light chains (HC, LC). PLA is inhibited by PLA inhibitor 1 and 2. |
| - | + | *'''Tissue PLA''' (TPA) which is involved in breakdown of blood clots and urokinase-type PLA [[Urokinase]]. | |
==3D structures of plasminogen activator== | ==3D structures of plasminogen activator== | ||
| Line 35: | Line 35: | ||
*Urokinase-type plasminogen activator see [[Urokinase]] | *Urokinase-type plasminogen activator see [[Urokinase]] | ||
}} | }} | ||
| + | == References == | ||
| + | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 10:20, 4 July 2016
Plasminogen activator (PLA) is a serine protease which converts plasminogen to plasmin. TPA structure contains heavy and light chains (HC, LC). PLA is inhibited by PLA inhibitor 1 and 2.
- Tissue PLA (TPA) which is involved in breakdown of blood clots and urokinase-type PLA Urokinase.
3D structures of plasminogen activator
Updated on 04-July-2016
